Analysis Group HEOR Consultants Present at ISPOR Europe 2023

December 6, 2023

Researchers from Analysis Group’s HEOR, Epidemiology & Market Access practice presented an educational symposium, podium presentation, and 13 research posters at ISPOR Europe 2023. The conference took place November 12 through 15, 2023, in Copenhagen, Denmark.

Analysis Group sponsored the educational symposium “Advancing Real-World Evidence Generation: Insights from Europe, the US, and China.” Managing Principal Eric Q. Wu moderated the panel discussion with panelists Vice Presidents Min Yang and Jia Zhong of Analysis Group and Grégoire Mercier of the University Hospital of Montpellier. The symposium investigated the expanding significance of real-world evidence (RWE) in health care, with examples of experiences and practices observed in Europe, the US, and China.

In a podium presentation, Managing Principal James Signorovitch presented the abstract “Comparability of Overall Survival in Real-World and Clinical Trial Data for BRAF+ Advanced Melanoma,” which he co-authored with Analysis Group Vice President Gautam Sajeev, Associates Sarah Kalia and Ryan Simpson, and Analysts Dana Christensen and Daisy Liu, as well as researchers from Pfizer and the USC Norris Comprehensive Cancer Center.

Analysis Group’s complete presentation guide is available here.